Amneal Files $522.7M Shelf for Class A Shares as Valuation Scrutiny Grows
Amneal Pharmaceuticals filed a shelf registration to issue up to $522.7m of Class A common shares, covering 28,942,098 securities. While the stock’s long-term performance remains strong, short-term momentum softened and the filing underscores potential dilution risk. The move is framed against a discounted valuation versus a $21 fair value estimate, raising questions about market caution.